Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity Pneumonitis

<b>Background:</b> Hypersensitivity pneumonitis (HP) represents a chronic lung disease with an unpredictable clinical course. There is a pressing need for clinically applicable prognostic biomarkers in patients with HP. <b>Methods:</b> This was an observational, retrospective study. We investigated the prognostic potential of complete blood count parameters in treatment-naïve patients diagnosed with HP between 15 December 2010 and 1 October 2023. Receiver operating characteristic (ROC) curve analysis identified the optimal cut-off thresholds for each parameter in terms of mortality prediction. <b>Results:</b> We included 129 patients diagnosed with HP [median age: 68.0 years (95% CI: 65.0 to 69.0), fibrotic HP: <i>n</i> = 85, 65.9%]. Patients with HP and an eosinophil count > 160 cells/μL [ROC curve, area under curve (AUC): 0.61] exhibited increased mortality risk compared to patients with HP and an eosinophil count ≤ 160 cells/μL [Kaplan-Meier, HR: 2.95 (95% CI: 1.36 to 6.42), <i>p</i> = 0.006]. Patients with HP and a monocyte count > 350 cells/μL (ROC curve, AUC: 0.52) had worse survival compared to patients with HP and a monocyte count lower than this threshold [Kaplan-Meier, HR: 2.48 (95% CI: 1.03 to 5.09), <i>p</i> = 0.04]. Patients with HP and an eosinophil-lymphocyte ratio (ELR) > 0.09 (ROC curve, AUC: 0.64) had a higher risk of mortality compared to patients with HP and ELR ≤ 0.09 [Kaplan-Meier, HR: 2.75 (95% CI: 1.3 to 5.78), <i>p</i> = 0.008]. <b>Conclusions:</b> This study demonstrated that eosinophil count, monocyte count, and ELR could be prognostic biomarkers in patients with HP. Further studies aiming to validate the prognostic potential of complete blood count parameters in patients with HP are greatly anticipated.

Authors

Institutions

Publication Details

Journal
Diagnostics
Published
2025-04-18
DOI
https://doi.org/10.3390/diagnostics15081038
Citations
1
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity Pneumonitis

Paschalis Ntolios, Fotios Sampsonas, Elisabeth Bendstrup, Evangelia Fouka et al.
1 citations
Diagnostics
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
1.52
article

Complete Blood Cell Count Parameters Predict Mortality in Patients with Hypersensitivity Pneumonitis

Paschalis Ntolios, Fotios Sampsonas, Elisabeth Bendstrup, Evangelia Fouka, Argyrios Tzouvelekis, Vasilina Sotiropoulou, Athena Gogali, Ουρανία Παπαϊωάννου, Despoina Papakosta, Vasilios Tzilas, Lykourgos Kolilekas, Demosthenes Bouros, Elli Malakounidou, Νikoletta Ρovina, Panagiota Tsiri, Spyridon Papiris, Paschalis Steiropoulos, Κonstantinos Κostikas, Effrosyni D. Manali, Matthaios Katsaras, Ioannis P. Tomos, Ioannis Christopoulos, Ιlias Papanikolaou, Eva Theohari
article en
1 citations

Abstract

<b>Background:</b> Hypersensitivity pneumonitis (HP) represents a chronic lung disease with an unpredictable clinical course. There is a pressing need for clinically applicable prognostic biomarkers in patients with HP. <b>Methods:</b> This was an observational, retrospective study. We investigated the prognostic potential of complete blood count parameters in treatment-naïve patients diagnosed with HP between 15 December 2010 and 1 October 2023. Receiver operating characteristic (ROC) curve analysis identified the optimal cut-off thresholds for each parameter in terms of mortality prediction. <b>Results:</b> We included 129 patients diagnosed with HP [median age: 68.0 years (95% CI: 65.0 to 69.0), fibrotic HP: <i>n</i> = 85, 65.9%]. Patients with HP and an eosinophil count > 160 cells/μL [ROC curve, area under curve (AUC): 0.61] exhibited increased mortality risk compared to patients with HP and an eosinophil count ≤ 160 cells/μL [Kaplan-Meier, HR: 2.95 (95% CI: 1.36 to 6.42), <i>p</i> = 0.006]. Patients with HP and a monocyte count > 350 cells/μL (ROC curve, AUC: 0.52) had worse survival compared to patients with HP and a monocyte count lower than this threshold [Kaplan-Meier, HR: 2.48 (95% CI: 1.03 to 5.09), <i>p</i> = 0.04]. Patients with HP and an eosinophil-lymphocyte ratio (ELR) > 0.09 (ROC curve, AUC: 0.64) had a higher risk of mortality compared to patients with HP and ELR ≤ 0.09 [Kaplan-Meier, HR: 2.75 (95% CI: 1.3 to 5.78), <i>p</i> = 0.008]. <b>Conclusions:</b> This study demonstrated that eosinophil count, monocyte count, and ELR could be prognostic biomarkers in patients with HP. Further studies aiming to validate the prognostic potential of complete blood count parameters in patients with HP are greatly anticipated.

DiagnosticsVol. 15(8)
Democritus University of Thrace (GR), University of Ioannina (GR), National and Kapodistrian University of Athens (GR), Aristotle University of Thessaloniki (GR), General University Hospital of Patras (GR), Aarhus University Hospital (DK), Corfu General Clinic (GR), G. Papanikolaou General Hospital (GR), Sotiria General Hospital (GR)
Openalex Percentile: Top 20%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.